Randomised Controlled Trial of Early Antivenom Administration in Australian Snakebite [ESAA]

Snake bites are not common in Australia, but cause severe effects and often occur in rural and regional parts of Australia. Antivenoms exist for the treatment of many of these …

CONDITION: Other

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Recruiting

%%tb-image-alt-text%%

LE16061 Healthy Volunteer Trial

A Phase 1, Single-Center, Open-label Study to Evaluate the Safety and Pharmacokinetics of Two Tablet Formulations of PRN1008. The purpose of this study is to investigate the relative bioavailability (the …

CONDITION:

GENDER: Both males and females

AGE GROUP: 18 to 65 years

TRIAL STATUS: Closed: follow-up complete

%%tb-image-alt-text%%

A Phase I/IIa Study of the Efficacy and Safety of ASN-002 in Adult Patients with Low-Risk Nodular Basal Cell Carcinoma

Have you been diagnosed with or suspected to have a nodular Basal Cell Carcinoma (BCC)?   CLINICAL RESEARCH STUDY We are seeking volunteers with nodular BCC to participate in a …

CONDITION: Cancer

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Recruiting

%%tb-image-alt-text%%

Atopic Dermatitis

This research project is testing the safety, tolerability and efficacy (the effect of the drug on the body) of AKP-11 administered to participants with atopic dermatitis. You are invited to …

CONDITION: Skin

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Completed

%%tb-image-alt-text%%

Genital Psoriasis

Genital Psoriasis  If you have psoriasis with genital involvement, you’re not alone. Up to two thirds of people with psoriasis report genital involvement at some point during their lives. That’s …

CONDITION: Skin

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Closed: follow-up continuing

%%tb-image-alt-text%%

Mild To Moderate Plaque Psoriasis

AKP-11 is being developed as a treatment for psoriasis. AKP-11 has been tested on a small population of psoriasis subjects previously, which showed a reduction in psoriasis severity. By participating …

CONDITION: Skin

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Completed

%%tb-image-alt-text%%

COPD – FLASH STUDY – Multi-centre

Are you aged 40 years or over? Do you suffer from COPD? Are you a current or previous smoker? Using Seretide? If you answered yes to these questions, you may be …

CONDITION: Respiratory

GENDER: Both males and females

AGE GROUP: 40 and above

TRIAL STATUS: Completed

%%tb-image-alt-text%%

CHRONIC PAIN – Survey Assessment

people suffering with Chronic Pain 1 visit of approximately 2 hours assessing a survey for people affected by Chronic Pain in Australia If you suffer from Chronic Pain or know someone who does, …

CONDITION: Other

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Completed

%%tb-image-alt-text%%

COPD – FLASH Study

 If you answered yes to these questions, you may be able to take part in a new research study.   Our Research Centre in Drummoyne is participating in the study. …

CONDITION: Respiratory

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Closed: follow-up continuing

%%tb-image-alt-text%%

An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression

This is a Phase 3, multi centre, open label, long term (up to 52 weeks) study of the safety and efficacy of esketamine administered by nasal spray in treatment resistant depression. Study participants will …

CONDITION: Mental Health

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Completed

%%tb-image-alt-text%%

ODYSSEY – Type 2 Diabetes and High Cholesterol

We are testing the effect of an investigational drug on reducing cholesterol in patients with Type 2 Diabetes who may be at risk of developing coronary heart disease.

CONDITION: Metabolic and Endocrine

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Recruiting